• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Search Results for: patent

USPTO, Small Businesses Talk Patent Reform, Harmonisation, Fee Diversion

02/11/2011 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment

The United States Patent and Trademark Office (USPTO) is working to ensure small businesses and independent inventors have the tools they need to obtain, protect and enforce their patents overseas, as well as domestically, in the wake of patent reform legislation enacted in the United States. Meanwhile, the office is also stepping up global patent harmonisation efforts.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Europe, Finance, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

Multiple Defendants In Patent Infringement Filing Under New US Law

28/10/2011 by Intellectual Property Watch Leave a Comment

A company has filed a patent infringement complaint in the Eastern District of Texas that names 30 defendants, including some of the largest US technology companies, a case that reflects a change in US law as passed last month.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Enforcement, English, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

Revised EPO Patent For Conventional Broccoli Has Public Interest Ramifications

27/10/2011 by William New, Intellectual Property Watch 2 Comments

A patent for a conventionally bred form of the common household vegetable broccoli appears to be on its way to acceptance by the European Patent Office following a change to the patent by the company filing it, according to sources. The decision not to revoke the patent, which has been the subject of protests and now calls for action in national courts, could clear the way for hundreds of other vegetable patents to follow, a source said.

Filed Under: IP Policies, Language, News, Themes, Venues, Biodiversity/Genetic Resources/Biotech, Development, English, Environment, Europe, Health & IP, Human Rights, IP Law, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Traditional and Indigenous Knowledge, United Nations - other

EU High Court Bans Patents On Human Embryo Stem Cells For Commerce

18/10/2011 by Dugie Standeford for Intellectual Property Watch 1 Comment

The European Union high court today outlawed the patenting of human embryo stem cells for scientific research or commercial purposes. The decision has forced European courts to examine the “ethical boundaries of patenting,” said Greenpeace, which challenged a German patent in the case. While there are alternate methods for obtaining stem cells, the ruling will nevertheless affect some research, one patent lawyer said.

Filed Under: IP Policies, Language, News, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Europe, Human Rights, IP Law, Innovation/ R&D, Patents/Designs/Trade Secrets

Medicines Patent Pool Signs Deal With Indian Generics Producer

11/10/2011 by William New, Intellectual Property Watch 2 Comments

The Medicines Patent Pool, which negotiates voluntary licences for lower pharmaceutical prices, today announced the signing of an agreement with generics producer Aurobindo Pharma Limited to manufacture antiretroviral medicines. The Patent Pool has recently come under criticism from AIDS activists concerned about its July licence agreement with drug company Gilead, and it remains to be seen if this action will address their concerns.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

EPO, European Commission Renew Commitment To Unitary Patent

06/10/2011 by Intellectual Property Watch 1 Comment

The head of the European Patent Office (EPO) and the European Commissioner for Internal Market and Services today renewed their commitment to introduce a unitary EU patent, which they say would significantly ease workloads and reduce costs for patent applicants.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Europe, Finance, Innovation/ R&D, Patents/Designs/Trade Secrets

US Patent Law Seen Opening Door To Global Harmonisation At WIPO

25/09/2011 by Rachel Marusak Hermann, Intellectual Property Watch 2 Comments

Just a week after US patent reform was signed into law, the Symposium of Intellectual Property Authorities opened with an air of celebration on 22 September at the World Intellectual Property Organization (WIPO). During the opening session, several keynote speakers congratulated United States Patent and Trademark Office Director David Kappos for the long-awaited legislation helping to harmonise the American patent process with the rest of the world.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Copyright Policy, English, Innovation/ R&D, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, WIPO

US Patent Reform Signed Into Law

16/09/2011 by Intellectual Property Watch 5 Comments

US President Obama today signed a bill into law that many patent professionals and international observers may never have thought they’d see: the widescale reform of US patent law. What the impact will be on the US economy or on other nations remains to be seen.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

Patent Reform Passes US Senate, Makes History; Obama to Sign: IP-Watch Analysis Shows Who Wins

09/09/2011 by Liza Porteus Viana, Intellectual Property Watch 1 Comment

The United States Senate on Thursday passed historic patent reform legislation – but not before some heated debate on the chamber’s floor. It now goes to President Obama for his signature. Intellectual Property Watch offers a look at who wins and what will now change.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, English, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

Senate Takes Up Patent Reform; Chairman Vows To Fight Amendments

07/09/2011 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment

The United States Senate on Tuesday was debating patent reform legislation that would make the first significant reforms to the US patent system in nearly 60 years.

Filed Under: IP Policies, Language, News, Subscribers, Themes, Venues, English, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 347
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting